FIELD: pharmacology.
SUBSTANCE: method for determination of mycophenolic acid concentration in the human blood plasma differs by chromatographic separation of the matrix components conducted using Kinetex Phenomenex C18 column (30×4.6 mm, 2.6 mcm) at a flow rate of 0.4 ml/min as the following conditions of gradient elution are met: from the beginning of the analysis, and up to 1 min, acetonitrile content in the mobile phase is 40%, water content is 60%; from 1 min to 1.5 min of the analysis, acetonitrilecontent linearly rises to 65%, water content linearly decreases to 35%; from 1.5 min to 2.0 min of the analysis, acetonitrile content linearly rises to 90%, water content linearly decreases to 10%; from 2.0 min to 2.5 min of the analysis, acetonitrile content is 90%, water content is 10%; from 2.5 min to 3.0 min of the analysis, acetonitrile content linearly decreases to 65%, water content linearly increases to 35%; from 3.0 min to 3.5 min of the analysis, acetonitrile content linearly decreases to 40%, water content linearly increases to 60%; from 3.5 min to the end of the analysis, acetonitrile content is 40%, water content is 60%.
EFFECT: increased accuracy of determination.
6 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINATION OF METHYLDOPE CONCENTRATION IN HUMAN BLOOD PLASMA | 2016 |
|
RU2642593C1 |
METHOD FOR DETERMINING AMIODARONE AND ITS MAIN METABOLITE DESETHYLAMIODARONE IN HUMAN BLOOD SERUM | 2020 |
|
RU2749566C1 |
METHOD OF QUANTIFICATION OF LEVODOPA IN BLOOD PLASMA | 2017 |
|
RU2665164C1 |
METHOD FOR DETERMINING TOPIRAMATE IN BLOOD PLASMA | 2016 |
|
RU2631613C1 |
METHOD OF DETERMINING CARNOSINE IN BIOLOGICAL MATERIALS | 2015 |
|
RU2585115C1 |
METHOD OF QUANTITATIVE DETERMINATION OF OKADAIC ACID IN SEAFOOD | 2017 |
|
RU2666247C1 |
METHOD OF DETERMINING PINOSTROBIN OXIME IN BLOOD PLASMA | 2015 |
|
RU2568876C1 |
METHOD OF QUANTIFICATION OF AMANTADINE IN BLOOD PLASMA | 2017 |
|
RU2650968C1 |
METHOD FOR SALICYLATES QUANTIFICATION IN BLOOD PLASMA | 2016 |
|
RU2622996C1 |
METHOD FOR MONITORING THE CONTENT OF ANTI-TUBERCULOSIS PREPARATIONS OF THE MAIN LINE AND THEIR TOXIC METABOLITES IN BLOOD PLASMA | 2018 |
|
RU2702998C1 |
Authors
Dates
2018-01-24—Published
2017-02-13—Filed